Synthesis, Characterization and Antibacterial Activities of Cu (II) Complex of Benzylpenicillin
Contenu principal de l'article
Résumé
The sudden uprising of resistant human pathogens is a challenge in current antimicrobial therapy, therefore the need to encourage the development of novel metal-based drugs The efficacy of the various organic therapeutic agents can often be enhanced upon coordination with a suitable metal ion. Cu (II) benzylpenicillin,[Cu(Bpen)] complex was synthesized by the reaction of benzylpenicillin with CuCl2.2H2O. The complex was characterized by melting point, solubility, colour, conductivity, elemental analysis, infrared, UV/Visible, 1HNMR and 13CNMR spectroscopy. The spectral data showed that the ligand benzylpenicillin behaved as a pentadentate ligand coordinating to the metal ion through OH, C=O of amide, C-O of ?-lactam, C=O of COOH and NH. A trigonal bypyramidal geometry have been proposed for [Cu(Bpen)]. The ligand and [Cu(Bpen) complex have been screened for their in vitro antibacterial activity against four gram positive strains (Staphyloccocus aureus, Bacillus substilis, Bacillus cereus and Enterococus feacalis) and four gram negative (Escherichia coli, Enterobacter clocae, Pneumonia aeruginosa and Campylobacter felus). It was deduced that [Cu(Bpen)] complex have improved antibacterial activity than benzylpencillin alone and it was evident that the overall potency of benzylpencillin was enhanced on coordination with copper ion.
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
Adelstein,S.J. andVallee,B.L. (1961).Copper metabolism in man.New England Journal of Medicine. 265: 892-897.
Anacona,J.R, and Figueroa,E.M. (1999).Synthesis and characterization of metal complexes with penicillin.Journal of Coordination Chemistry. 48(2): 181-189.
Bamigboye,M.O., Obaleye,J.A. andAbdulmolib, S. (2012). Synthesis, characterization and antimicrobial activity of some mixed sulfamethaxazole-cloxacillin metal drug complexes. International Journal of Chemistry. 22(2): 105-108.
Bonham, M., Jacqueline, M., Bernadette,M.H and Strain,J.J. (2002).The immune system as a physiological indicator of marginal copper status?British Journal of Nutrition 87: 393–403.
Chohan,Z.H. and Supuran, C.T. (2006).Metalloantibiotics: Synthesis, characterization and in-vitro antibacterial studies on cobalt (II), copper (II), nickel (II) and zinc (II) complexes with cloxacillin. Journal of Enzyme Inhibition Medicinal Chemistry. 21(4): 441 – 44.
Chohan,Z.H., Supuran,C.T. andScozzafara, A. (2004).Metalloantibiotics: Synthesis and Antibacterial Activity of Cobalt(II), Copper(II), Nickel(II) and Zinc(II) complexes of Kefzol. Journal of Enzyme Inhibition and Medicinal Chemistry. 19(1): 79-84.
Christen, Y. (2000). Oxidative stress and Alzheimer’s disease.American Journal of Clinical Nutrition. 71: 621-629.
Davis, C.D. (2003). Low dietary copper increases fecal free radical production, fecal water alkaline phosphatase activity and cytotoxicity in healthy men. Journal of Nutrition.133(2): 522-527.
Geary,W.J. (1971).The use of conductivity measurements in organic solvents for the characterization of coordination compounds.Coordination Chemistry Reviews. 7(1): 81-122.
Harris,E.D., Qian, Y., Tiffany-Castiglioni, E., Lacy,A.R. and Reddy, M.C. (1998). Functional analysis of copper homeostasis in cell culture models: a new perspective on internal copper transport. American Journal of Clinical Nutrition. 67: 988-995.
Jimenez-Garido, N, Perello, L., Ortiz, R., Alzuet, G., Gonzalez-Alvarez, M,, Canton, E., LiuGonzalez, M., Garcia-Granda, S. and Perez-Priede, M. (2005). Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin. Journal of Inorganic Biochemistry. 99: 677-689.
Joseph, M., Suni, V., Kurup, M.R., Nethaji, M., Kishore, A. and Bhat, S. (2004). Structural, spectral and antimicrobial studies of copper (II) complexes of 2-benzoylpyridineN(4)-cyclohexylthiosemicarbazone.Polyhedron. 23(18): 3069-3080.
Kostova, I. (2010). Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications-part II.Anticancer Agents in Medicinal Chemistry. 10: 352-353.
Moues,C.M., Heule, F.,Legerstee, R. andHovius, R.N. (2009). Topical Negative Pressure in Wound Care Effectiveness and guidelines for clinical application. Ostomy and wound management. 55: 16-32.
Pahontu, E., Paraschivescu, C., Poirier, D., Oprean, C., P?unescu, V., Gulea, A., Ro?u, T. andBratu, O (2016). Synthesis and characterization of Novel Cu(II), Pd(II) and Pt(II) complexes with 8-Ethyl-2-hydroxytricyclo(7.3.1.02,7)tridecan-13-one-thiosemicarbazone: Antimicrobial and in vitroAntiproliferative Activity. Molecules. 21(5): 674-678
Patole, J., Sandbhor, U.,Subhash, P.,Deobagkar,D.N. Anson,C.E. and Powell,A (2003). Structural chemistry and in vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against Mycobacterium smegmatis.Bioorganic Medicinal Chemistry Letters. 13: 51-55.
Rafique, S., Idrees, M. Nasira, A. Akbar, H.and Atha, A. (2010).Transition Metal Complexes as Potential Therapeutic Agents. Biotechnological and Molecular Biological review. 5(2): 38-45.
Rakel, D. (2007). Integrative Medicine (2nd edition), Elsevier.The Journal of science and healing.3(5): 543-544.
Rottkamp, C.A.Nunomura, A.,Raina,A.K., Sayre,L.M., Perry,G..and Smith, M. (2000). Oxidative stress, antioxidants, and Alzheimer’s disease.Alzheimer Disease Associated Disorders. 14: 62-66.
Schaefer, M. and Gitlin, J.D. (1999). Genetic disorders of membrane transport IV-Wilson’s disease and Menkes disease.American Journal of Physiology, 311 - 314
Shechter, Y. andKarlish,S.D.J.(1980). Insulin-like stimulation of glucose oxidation in rat adipocytes by Vanadyl (IV) ions.Nature. 284: 556-558.
Strausak, D., Mercer,J.F., Dieter, H.H., Stremmel, W. andMulthaup, G. (2001).Copper in disorders with neurological symptoms: Alzheimer’s, Menkes, and Wilson diseases.Brain Research Bulletin55(2): 175-185.
Thompson,K.H., McNeill,J.H. andOrvig C.(1999). Vanadium compounds as insulin mimics, Chemical Reviews. 99: 2561 – 2571.
Turan, N., Körkoca, H., Adigüzel, R., Çolak, N. andBuldurun, K. (2015). Synthesis, structural characterization and biological activity of novel cyclohexane-1,3-dione ligands and their metal complexes. Molecules 20(5): 9309-9325.
Witkop, B andRamachandran,L.K. (1964). Progress in Non-enzymatic Selective Modification and Cleavage of Proteins. Metabolism13(10):1016-1025.